NASDAQ · AXLA
Healthcare · Biotechnology
$4.58
Up+$0.00 (+0.00%)
Updated Aug 25, 2026, 3:04 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
AXLA does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning AXLA.
AXLA research
Company profile and research snapshot.
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 16, 2023 | HC Wainwright & Co. | Neutral | — |
| Dec 16, 2022 | SVB Leerink | Market Perform | — |
| Dec 15, 2022 | HC Wainwright & Co. | Neutral | — |
| Nov 2, 2022 | Chardan Capital | Buy | — |
| Oct 3, 2022 | HC Wainwright & Co. | Buy | — |
No generated briefing is available yet.
MarketWatch · Sep 15, 2023
Shares of Arm Holdings and eGain were higher on Friday, while Adobe and Axcella Health were under pressure. Auto companies Ford and GM were also moving lower after a strike was called.
Benzinga · Sep 13, 2023
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.11% to 34,685.47 while the NASDAQ rose 0.39% to 13,827.83. The S&P 500, also rose, gaining, 0.25% to 4,473.00. Check This Out: These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts Leading and Lagging Sectors Consumer discretionary shares jumped by 0.8% on Wednesday. In trading on Wednesday, materials shares fell by 0.3%. Top Headline The annual inflation rate in the U.S. rose for a second consecutive month to 3.7% in August from 3.2% in the previous month, and also above market estimates of 3.6%. Consumer prices increased 0.6% month-over-month in August following a 0.2% growth in July. Equities Trading UP Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares shot up 73% to $0.2135. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of $0.10/less for 10 consecutive trading days. Shares of ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) got a boost, shooting 46% to $0.1881. Axcella Health Inc. (NASDAQ: AXLA) shares were also up, gaining 27% to ...
PennyStocks · Sep 13, 2023
Are you prepared for the future of trading penny stocks? The post What Will the Future of Trading Penny Stocks Look Like? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks · Sep 9, 2023
Can these tips help you to choose the right industry to find penny stocks to buy The post Choosing the Right Industry to Find Penny Stocks to Buy appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AXLA.
No results
No recent SID articles mention AXLA.
